Recombinant DNA technologyRecombinant DNA technology and other aspects of biotechnology are a far newer area of pharmaceutical research and development than areas related to small molecule pharmaceuticals, and the methods employed in all areas of the drug development process, from drug discovery to the manufacturing protocols, equipment, control parameters and testing methodologies required by the FDA are substantially different than those used with small molecule drugs. Beginning with the elucidation of the structure of DNA, advances in molecular biology techniques have led to dramatic progress in medical research, disease diagnosis and drug development and have introduced a new vocabulary to the pharmaceutical industry.
CITATION STYLE
Nagel, K. M. (2018). Principles of Recombinant DNA Technology (pp. 1–29). https://doi.org/10.1007/978-3-319-98428-5_1
Mendeley helps you to discover research relevant for your work.